This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,066.80 firm fixed-price delivery order is for the supply of UBRELVY 100 MG TABLET UD 10S, a medication used for the treatment of migraines. The contract has an ultimate completion date of July 9, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of UBRELVY 100 mg tablets, a medication used to treat migraine. The contract has a firm fixed price of $1,247.95 and a performance period ending on June 13, 2025. The award is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor and holds a...
This federal contract award, valued at $13,275.97, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of UBRELVY 100 MG TABLET UD 16S, a medical product, and has an ultimate completion date of November 20, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,657.18 firm fixed-price contract is for the delivery of UBRELVY 100 MG TABLET UD 10S, a medication used to treat migraines. The contract has a performance period ending on May 6, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,422.37 firm fixed-price delivery order is for the supply of 100 mg UBRELVY tablets, a medication used for the treatment of migraine. The contract award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,414.93 firm fixed-price delivery order is for the supply of UBRELVY 100 MG TABLET UD 10S, a medication used to treat migraines. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to provide a comprehensive range...
This federal contract award from the Defense Logistics Agency (DLA) is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,162.21 firm fixed price delivery order is for the supply of UBRELVY 100 MG TABLET UD 10S, a medication used for the treatment of migraines. This order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 through November...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $5,297.45 firm fixed-price contract is for the delivery of UBRELVY 100 MG TABLET UD 10S, a medication used to treat migraine. The contract has an ultimate completion date of June 14, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of UBRELVY 50 MG TABLET UD 10S. The contract has a firm fixed price of $1,771.42 and an ultimate completion date of May 22, 2025. The contract is not set aside and is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds with DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,117.94 firm fixed-price delivery order is for the supply of 50 mg UBRELVY tablets, a prescription medication used for treating migraine. The award is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...